Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/11952542
Conclusion of this study
We conclude that zinc sulphate at a dose of 10 mg kg(-1) daily seems to be a highly efficacious therapeutic option for recalcitrant viral warts and proved to be safe with few adverse effects.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study